Skip to main content
. Author manuscript; available in PMC: 2016 Jan 14.
Published in final edited form as: Nucl Med Biol. 2011 Sep 29;39(2):215–226. doi: 10.1016/j.nucmedbio.2011.07.007

Table 4.

Expression of TH, NET, and VMATs in tumor samples (0=less than 10% of tumor cells positive; 1+=10–25% positive cells; 2+=25–50% positive cells, presented as moderate staining; 3+=50–75% positive cells, moderate to strong staining; and 4+=more than 75% of tumor cells positive, strong staining)

Location TH NET VMAT1 VMAT2 [18F]-DA [18F]-DOPA
(SUVmax)
Adrenal 1 4+ 2+ 1+ 4+ 2.15 6.46
Adrenal 2 4+ 3+ 1+ 3+ 1.98 5.79
Bone 4+ 2+ 0 0 1.42
Liver 1 3+ 1+ 0 3+ 2.46 3.31
Liver 2 4+ 3+ 1+ 4+ 1.89 2.79
Liver 3 2+ 0 0 0 3.24
Lung 2+ 4+ 0 3+ 1.15
Ovary 4+ 2+ 1+ 2+ 1.92 3.05
s.c. 1 4+ 2+ 0 2+ 1.88
s.c. 2 3+ 3+ 0 3+ 2.25
s.c. 3 4+ 4+ 0 2+ 2.09

[18F]-DA and [18F]-DOPA PET uptake in organ metastatic and s.c. tumors expressed in SUVmax; calculated from images after 60–70 min after administration. Numbers 1–3 indicate number of samples. A dash sign “—” presents SUVmax values less than 0.3 for both [18F]-DA and [18F]-DOPA.